• Myeloma: Biology and Management

Myeloma: Biology and Management

0.0 (0 reviews)
In stock (1 available)
SKU SHUB109546
$179 $130.09
Free Shipping within the US
Est. Date: Jan 3, 2026

First prize winner in Haematology category of British Medical Association Medical Book Awards 2004!Completely revised and updated, the 3rd Edition of this premier resource provides cutting-edge coverage of the epidemiology, immunology, and haematology of myeloma-all in one convenient reference. A team of leading international authorities in myeloma research present a worldwide perspective on the most recent developments in management and therapeutic options, as well as the latest clinical understanding of the disease. Covers epidemiology, immunology, and hematology of myeloma - all in a one-stop resource. Provides new information on the biology, staging, and treatment of myeloma Offers new chapters on cytogenetics of multiple myeloma, molecular profiling of myeloma, prognostic factors, and novel agents for multiple myeloma, including those targeting tumours and microenvironment Presents the most recent breakthroughs in treatment, including various new drugs of proven efficacy such as Proteasome inhibitor Bortezomib, immunomodulatory drug Revamid, and controversial thalidomide, as well as treatment options just on the horizon Includes up-to-date information on gene micro-array profiling studies, which impact myeloma pathogenesis and identify targets of sensitivity versus resistance to new therapies

  • Author(s): James S. Malpas MD DPhil FRCP FRCR FRCPCH, Daniel E. Bergsagel CM MD DPhil, Robert A. Kyle MD, Kenneth C. Anderson MD
  • Publisher: Saunders
  • Language: en
  • Pages: 430
  • Binding: Hardcover
  • Edition: 3
  • Published: 2004-01-09
  • Dimensions: Height: 10.75 Inches, Length: 8.5 Inches, Weight: 3.0093098763 Pounds, Width: 1 Inches
  • Estimated Delivery: Jan 3, 2026
Customer Reviews
0.0 (0 reviews)
No Reviews Yet

Be the first to review this book!